Divya B. Reddy

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/f08dec40-c946-11ed-8462-993dfb204153.jpg

First Name

Divya

Last Name

Reddy

NPI

1588828370

Faculty ID

14312

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman'; background-color: #fefefe;"><strong><span style="font-size: 12pt; font-family: Calibri;">Education:</span></strong></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman'; background-color: #fefefe;"><span style="font-size: 12pt; font-family: Calibri;">Dr. Reddy earned her medical degree from Padmashree Dr. D. Y. Patil Medical College, India. She completed a master's degree in clinical epidemiology from Boston University School of Public Health prior to starting her Internal Medicine Residency training at Boston University Medical Center. Her post-graduate training also included a Fellowship in Pulmonary and Critical Care Medicine from Boston University Medical Center with a particular focus on pulmonary infections and associated lung destruction.&nbsp;&nbsp;</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman'; background-color: #fefefe;"><strong><span style="font-size: 12pt; font-family: Calibri;">Research Interests:</span></strong></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman'; background-color: #fefefe;"><span style="font-size: 12pt; font-family: Calibri;">Dr. Reddy has been involved in several patient-oriented research projects in pulmonary infections. As an investigator in the Regional Prospective&nbsp;Observational Research in Tuberculosis (RePORT) cohort in Puducherry and Tamil Nadu, India&nbsp;her work focused on the impact of smoking and biomass fuel use on TB Disease and its treatment outcomes.&nbsp;She is&nbsp;currently developing a database of patients with non-tuberculous mycobacterial infections seen at Montefiore Medical Center in collaboration with the Division of Infectious Diseases. The goal of this project is to better characterize the natural history&nbsp;and clinical outcomes of these infections.&nbsp;&nbsp;She is also involved in the&nbsp;Women&rsquo;s Interagency HIV Study (WIHS) as the Bronx site pulmonologist and co-investigator to assess the impact of HIV on the development of chronic lung diseases.</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman'; background-color: #fefefe;"><span style="font-size: 12pt; font-family: Calibri;"><strong>Clinical Interests:</strong></span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria;"><span style="font-family: Calibri; background-color: #fefefe;">1. Bronchiectasis &nbsp; &nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria;"><span style="font-family: Calibri; background-color: #fefefe;">2. Tuberculosis</span></p>
<p class="MsoNormal" style="margin: 0in -67.5pt 0.0001pt 0in; font-size: medium; font-family: Cambria;"><span style="font-family: Calibri; background-color: #fefefe;">3. Nontuberculous Mycobacterial (NTM) Infections &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria;"><span style="font-family: Calibri; background-color: #fefefe;">4. Obstructive lung diseases &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria;"><span style="font-family: Calibri; background-color: #fefefe;">5. COVID-19</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria;">&nbsp;</p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman'; background-color: #fefefe;"><strong><span style="font-size: 12pt; font-family: Calibri;">Board Certification:</span></strong></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman'; background-color: #fefefe;"><span style="font-size: 12pt; font-family: Calibri;">Dr. Reddy is board-certified in Internal Medicine, Pulmonary and Critical Care Medicine and is a<span class="apple-converted-space">&nbsp;</span><span style="border: 1pt none windowtext; padding: 0in;">member of numerous professional societies, including the American Thoracic Society and the Society of Critical Care Medicine.</span></span></p>

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Bronchiectasis, Nontuberculous Mycobacterial infections, COPD, Asthma, Interstitial Lung Disease<quillbot-extension-portal></quillbot-extension-portal><quillbot-extension-portal></quillbot-extension-portal>

Research Focus

Bronchiectasis, Nontuberculous mycobacterial infections.<quillbot-extension-portal></quillbot-extension-portal>

Elsevier Profile

Selected Publications

<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria; text-align: justify; text-indent: 4.5pt;"><strong><span style="font-family: Calibri;">Original Publications:</span></strong></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria; text-align: justify; text-indent: 4.5pt;"><span style="font-family: Calibri;">&nbsp;</span></p>
<p class="MsoNormalCxSpMiddle" style="margin: 0in -0.25in 0.0001pt 27pt; text-indent: -22.5pt;"><span style="font-family: Calibri;">1.&nbsp;&nbsp;&nbsp;&nbsp;<strong>Reddy D</strong>, Little F; Glucocorticoid-Resistant Asthma: More than meets the eye;&nbsp;<em>J Asthma</em>&nbsp;December 2013, Vol. 50, No. 10, Pages 1036-1044, PMID 23923995</span></p>
<p class="MsoNormalCxSpMiddle" style="margin: 0in -0.25in 0.0001pt 27pt; text-indent: -22.5pt;"><span style="font-family: Calibri;">2.&nbsp;&nbsp;&nbsp;&nbsp;<strong>Reddy D</strong>, O&rsquo;Donnell MR, Welter-Frost AM, Coe A, Horsburgh CR. Discordance between Tuberculin Skin Test and Interferon Gamma Release Assay is Associated with Previous Latent Tuberculosis Infection Treatment.&nbsp;<em>Mycobact Dis</em>&nbsp;2016, 6:227. doi: 10.4172/2161-1068.1000227.</span></p>
<p class="MsoNormalCxSpMiddle" style="margin: 0in -0.25in 0.0001pt 27pt; text-indent: -22.5pt;"><span style="font-family: Calibri;">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strong>Divya Reddy</strong>, Jacob Walker, Gary Brandeis MD, Matt Russell MD, C Robert Horsburgh Jr, Natasha Hochberg;&nbsp;Latent Tuberculosis Infection Screening Practices in Long-Term Care Facilities<em>;&nbsp;J Am Geriatr Soc</em>, 2017, 65: 1145&ndash;1151. doi:10.1111/jgs.14696, PMID 28467605</span></p>
<p class="MsoNormalCxSpMiddle" style="margin: 0in -0.25in 0.0001pt 27pt; text-indent: -22.5pt;"><span style="font-family: Calibri;">4.&nbsp; &nbsp; &nbsp;</span><strong style="font-family: Cambria; font-size: 12pt;"><span style="font-family: Calibri;">Divya Reddy</span></strong><span style="font-size: 12pt; font-family: Calibri;">, Yicheng Ma, Subitha Lakshminarayanan, Swaroop Sahu, Laura F. White, Ayiraveetil Reshma, Gautam Roy, Padmini Salgame, Selby Knudsen, Jerrold J. Ellner, C. Robert Horsburgh, Jr., Sonali Sarkar, Natasha S. Hochberg, Severe Undernutrition in Children Affects Tuberculin Skin Test Performance in Southern India. <em>PLoS ONE 16(7): e0250304. https://doi.org/10.1371/journal. pone.0250304, </em></span><span style="font-size: 12pt; font-family: Calibri;">PMID 34270546</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Cambria;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Cambria;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in -0.25in 0.0001pt 40.5pt; font-size: medium; font-family: Cambria; text-indent: 4.5pt;"><span style="font-family: Calibri;">&nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in -0.25in 0.0001pt 40.5pt; font-size: medium; font-family: Cambria; text-indent: -0.5in;"><strong><span style="font-family: Calibri;">Book Chapters:</span></strong></p>
<p class="MsoNormal" style="margin: 0in -0.25in 0.0001pt 40.5pt; font-size: medium; font-family: Cambria; text-indent: 4.5pt;"><span style="font-family: Calibri;">&nbsp;</span></p>
<p class="MsoNormalCxSpMiddle" style="margin: 0in -0.25in 0.0001pt 27pt; text-indent: -22.5pt;"><span style="font-family: Calibri;">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;O&rsquo;Donnell M,&nbsp;<strong>Reddy D</strong>, Saukkonen J; Antimycobacterial agents; 19^th&nbsp;Edition of&nbsp;<em>Harrison&rsquo;s Principles of Internal Medicine</em>, McGraw-Hill Professional, 2015. Volume 2. Chapter 205e, p. 1132-41</span></p>
<p class="MsoNormalCxSpMiddle" style="margin: 0in -0.25in 0.0001pt 27pt; text-indent: -22.5pt;"><span style="font-family: Calibri;">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strong>Reddy D</strong>, O&rsquo;Donnell M; Antimycobacterial agents; 20^th&nbsp;Edition of&nbsp;<em>Harrison&rsquo;s Principles of Internal Medicine,&nbsp;</em>McGraw-Hill Professional, 2018. Volume 1. Chapter 176, p. 1270-79</span></p>
<p class="MsoNormalCxSpMiddle" style="margin: 0in -0.25in 0.0001pt 27pt; text-indent: -22.5pt;"><span style="font-family: Calibri;">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strong>Reddy D</strong>, Saukkonen J; Hepatoxicity associated with anti-tuberculosis treatment;<strong>&nbsp;</strong>3^rd&nbsp;Edition of&nbsp;<em>Textbook of</em>&nbsp;<em>Tuberculosis and Nontuberculous Mycobacterial Diseases,</em>&nbsp;Jaypee Brothers Medical Publishers, 2019. Chapter 45, p. 637-643</span></p>
<p class="MsoNormalCxSpMiddle" style="margin: 0in -0.25in 0.0001pt 27pt; text-indent: -22.5pt;"><span style="font-family: Calibri;">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strong>Divya Reddy</strong>, Jerrold Ellner; Pathogenesis of Tuberculosis; 6^th&nbsp;Edition of&nbsp;<em>Clinical Tuberculosis</em>, CRC Press, 2020. Chapter 4, p. 51-76</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria;"><span style="font-family: Calibri;">&nbsp;</span></p>

EMR ID

73329

Biography

<p>Divya Reddy, MD, MPH, is Program Director, Pulmonary and Critical Care Fellowship and Associate Professor, Medicine at Montefiore Einstein. Her clinical focus centers on bronchiectasis, nontuberculous mycobacterial infections, chronic obstructive pulmonary disease (COPD), asthma and interstitial lung disease.</p><p>After earning her Bachelor of Medicine, Bachelor of Surgery at Dr. D.Y. Patil Medical College in Mumbai, India in 2006, Dr. Reddy moved to the United States to continue her medical training, earning her Master of Public Health at Boston University in 2008. She remained there to complete her internal medicine internship in 2009, followed by her internal medicine residency in 2011. Dr. Reddy then completed a pulmonary and critical care fellowship at Boston University in 2014.</p><p>Building on her clinical experience, Dr. Reddy&rsquo;s research is focused on bronchiectasis and nontuberculous mycobacterial infections. She has been principal investigator and co-investigator on several funded research projects, and her work has been published in numerous peer-reviewed journals, book chapters, review articles and abstracts. She has also given national and international invited presentations, and is a reviewer for scientific journals including the <em>Journal of American Geriatric Society</em>, <em>Annals of American Thoracic Society</em> and the <em>Journal of Infectious &amp; Non-Infectious Diseases</em>, among others.</p><p>Dr. Reddy is board certified in Pulmonary Medicine and Critical Care Medicine by the American Board of Internal Medicine. She is a member of the American Thoracic Society, the American College of Chest Physicians and the Association of Pulmonary and Critical Care Medicine Program Directors. In 2014 and 2015, Dr. Reddy received the Potts Memorial Foundation Grant award.</p>

Visit Type ID

2542

Is Open Scheduling

On

David J. Prezant

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/4db93d60-5bd2-11ef-9c26-99fb988c3389.jpg

First Name

David

Last Name

Prezant

NPI

1184713489

Faculty ID

2422

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Dr. David Prezant is the Chief Medical Officer at the Office of Medical Affairs for the Fire Department of the City of New York (FDNY). Dr. Prezant directs all medical protocol development for both day-to-day operations and homeland security issues. He is also Co-Director of the FDNY World Trade Center Medical Monitoring Program and the Senior Pulmonary Consultant for FDNY.</p>

<p>Dr. Prezant is a member of the Institute of Medicine's Committee on Personal Protective Equipment in the Workplace, the National Fire Protection Association's Health and Safety Committee, and the International Association of Firefighters Redmond Medical Advisory Board. He is a Professor of Medicine at the Albert Einstein College of Medicine; Director of Albert Einstein Medical School's Pulmonary Course for medical students and the Research Director for their Unified Pulmonary Division.</p>

<p>Dr. Prezant responded on 9/11/01 to the World Trade Center and was present during the collapse and its aftermath. Since that day, he and Dr. Kelly (FDNY's Chief Medical Officer at the Bureau of Health Services) have initiated a multi-million dollar medical monitoring and treatment program for FDNY firefighters funded by FDNY, the Centers for Disease Control and Prevention (CDC) and the National Institute for Occupational Safety and Health (NIOSH).</p>

<p>Dr. Prezant is the Principal Investigator for the FDNY Data Coordinating Center for the WTC Medical Monitoring Program and is on the Steering Committee for the WTC Medical Monitoring Program. He served as a member of the EPA WTC Technical Advisory Committee, the NYC Dept of Health WTC Registry Scientific Advisory Board, the NYS Governor's WTC panel and the NYC Mayor's medical advisory board.</p>

<p>Dr. Prezant has written extensively on pulmonary physiology, firefighter health and safety and since 9/11 on the health impact of World Trade Center Collapse on NYC Firefighters and EMS rescue workers. His group was the first to describe WTC Cough Syndrome (New England Journal of Medicine 2002) and has published extensively on this subject in the CDC MMWR, American Journal of Respiratory and Critical Care Medicine, Chest and Environmental Health Perspectives.</p>

<p>His major research interest is in determining the mechanisms responsible for accelerated decline in longitudinal pulmonary function and/or airway hyperreactivity in firefighters after WTC exposure. Other interests are in determining the mechanisms responsible for the increased incidence of sarcoidosis in firefighters after WTC exposure.</p>

<p><strong>Clinical Specialty Areas</strong></p>

<ul>
<li>environmental and occupational lung disease</li>

<li>firefighters respiratory disease</li>

<li>disaster medicine</li>

<li>pulmonary embolism</li>

<li>general pulmonary medicine</li>
</ul>

<p><strong>More</strong></p>

<p><a href="/medicine/pulmonarymedicine/pulmonary_about.aspx?id=14538">Seven Years Later, a Cough and a Covenant</a> (September 10, 2008)</p>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

Selected Publications

<ol>
<li>World Trade Center site. N Eng J Med 2002;347:806-15.</li>

<li>Banauch GI, McLaughlin M, Hirschhorn R, Corrigan M, Kelly KJ, Prezant DJ. Injuries and Illnesses among New York City Fire Department rescue workers after responding to the World Trade Center Attacks. MMWR 2002;51:1-5.</li>

<li>Prezant DJ, Kelly KJ, Jackson B, Peterson D, Feldman D, Baron S, Mueller CA, Bernard B, Lushniak B, Smith L, BerryAnn R, Hoffman B. Use of respiratory protection among responders at the World Trade Center Site, New York City, September 2001. MMWR 2002;51:6-8.</li>

<li>Rom WN, Weiden M, Garcia R, Ting AY, Vathesatogkit P, Tse DB, McGuinness G, Roggli V, Prezant DJ. Acute eosinophilic pneumonia in a New York City firefighter exposed to world trade center dust. Am. J. Resp. Crit. Care Med. 2002;166:797-800.</li>

<li>Banauch GI, Alleyne D, Sanchez R, Olender K, Weiden M, Kelly KJ, and PREZANT DJ. Persistent bronchial hyperreactivity in New York City firefighters and rescue workers following collapse of World Trade Center. Am. J. Resp. Crit. Care Med. 2003; 168:54-62.</li>

<li>Edelman P, Osterloh J, Pirkle J, Grainger J, Jones R, Blount B, Calafat A, Turner W, Caudill S, Feldman DM, Baron S, Bernard BP, Lushniak BD, Kelly KJ, PREZANT DJ. Biomonitoring of chemical exposure among New York City firefighters responding to the World Trade Center fire and collapse. Environ Health Perspect, 2003; 111:1906-1911.</li>

<li>Feldman DM, Baron S, Mueller CA, Bernard BP, Lushniak BD, Kelly KJ, PREZANT DJ. Initial symptoms, respiratory function and respirator use in New York City firefighters responding to the World Trade Center (WTC) disaster. Chest 2004;125:1256-64.</li>

<li>World Trade Center dust. Environ Health Perspect, 2004; 112:1564-1569.</li>

<li>Banauch GI, Dhala A, Alleyne D, Alva R, Santhyadka G, Krasko A, Weiden M, Kelly KJ, Prezant DJ. Bronchial hyperreactivity and other inhalation lung injuries in rescue/recovery workers after the World Trade Center collapse. Crit Care Med. 2005;33:S102-S106.</li>

<li>World Trade Center site. Curr Opin Pulm Med 2005; 11:160-8.</li>

<li>Paul Greene, Dianne Kane, Grace Christ, Sallie Lynch and Malachy Corrigan. FDNY crisis counseling: innovative responses to 9/11 firefighters, families, and communities. Published 2005.A textbook in counseling at FDNY after WTC.</li>

<li>Bars MP, Banauch GI, Appel DW, Andreaci M, Mouren P, Kelly KJ, Prezant DJ. Tobacco Free with FDNY: The New York City Fire Department World Trade Center Tobacco Cessation Study. Chest 2006; 129:979-987.</li>

<li>World Trade Center exposure in the New York City Fire Department. Am. J. Respir. Crit. Care Med. 2006; 174:312-319.</li>

<li>Friedman S, Cone J, Eros-Sarnyai M, Prezant D,m Szeinuk J, Clark N, Milek D, Levin S, Gillio R. Clinical guidelines for adults exposed to World Trade Center Disaster (Respiratory and Mental Health). City Health Info (CHI), NYC Department of Health and Mental Hygiene. September 2006</li>

<li>Lioy PJ, Pellizzari E, and Prezant DJ. Understanding and learning from the WTC Aftermath and its affect on health through Human Exposure Science. Environ. Science Technology. November 15, 2006 ; 6876-6885.</li>

<li>Izbicki G, Chavko R, Banauch GI, Weiden M, Berger K, Kelly KJ, Aldrich TK and Prezant DJ. World Trade Center Sarcoid-like Granulomatous Pulmonary Disease in New York City Fire Department Rescue Workers. CHEST (In press)</li>

<li>Izbicki G, Chavko R, Banauch GI, Weiden M, Berger K, Kelly KJ, Hall C, Aldrich TK and Prezant DJ.&#160; World Trade Center Sarcoid-like Granulomatous Pulmonary Disease in New York City Fire Department Rescue Workers.&#160; Chest, 2007;131:1414-1423</li>

<li>Weiden M, Banauch G, Kelly KJ, and Prezant DJ. Environmental and Occupational Medicine. Firefighters Health and Health Effects of the World Trade Center Collapse. Pgs 477-490. 4th Edition, Edited by Rom WN and Markowitz S. Lippincott-Raven Inc. Philadelphia, 2007.</li>

<li>Alvarez J, Rosen C, Davis K, Smith G, Corrigan M. Stay Connected : psychological services for retired firefighters after 11 September 2001.&#160; PreHospital Disaster Med. 2007 ;22 :49-54.</li>

<li>Menendez AM, Molloy J., Magaldi MC. Health responses of New York City firefighter spouses and their families post-September 11, 2001 terrorist attacks.&#160; Issues Ment Health Nurs. 2006; 27:905-17.</li>

<li>Kelly KJ, Niles J, McLaughlin MT, Carrol S, Corrigan M, Al-Othman F, and Prezant DJ.&#160; World Trade Center health Impacts on FDNY Rescue Workers - a six year assessment, September 2001 to 2007.&#160; Fire Department of the City of New York, October 2007. Available on-line at: <a href="http://www.nyc.gov/html/om/pdf/2007/wtc_health_impacts_on_fdny_rescue_w…; target="_blank">http://www.nyc.gov/html/om/pdf/2007/wtc_health_impacts_on_fdny_rescue_w…;

<li>Prezant DJ. WTC Cough Syndrome and its Treatment. Lung. 2008 ; 186 :94S-102S.</li>

<li>Banauch GI, Izbicki G, Chavko R, Christodoulou V, Weiden MD, Webber MP, Cohen HW, Gustave J, Aldrich TK, Kelly KJ, and Prezant DJ. Trial of Prophylactic Inhaled Steroids to Prevent or Reduce Pulmonary Function Decline, Pulmonary Symptoms and Airway Hyperreactivity in Firefighters at the World Trade Center Site. Disaster Medicine and Public Health Preparedness 2008; 2:33-39.</li>

<li>Prezant DJ, Levin S, Kelly KJ, Aldrich TK.&#160; Upper and Lower Respiratory Diseases after Occupational and Environmental Disasters.&#160; Mt. Sinai Medical Journal (In Press).&#160;&#160;&#160;&#160;&#160;</li>
</ol>

<p>&#160;</p>

EMR ID

3430

Is Open Scheduling

Off

Kenneth L. Pinsker

https://assets.montefioreeinstein.org/profiles/images/physphoto/Pinsker_Kenneth_MD_420x504.jpg

First Name

Kenneth

Last Name

Pinsker

NPI

1306936273

Faculty ID

3368

CMO Specialties

Clinical Terms

Employment Status

Per Diem

Patient Type

Adult

Department

Languages

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Dr. Kenneth Pinsker is Professor Emeritus of Medicine at Einstein and an attending physician at Montefiore. He is the former Chief of the Pulmonary Service at the Moses Division and the former Director of the Pulmonary Intensive Care Unit. He is currently a preceptor in the Pulmonary Clinic and makes teaching rounds on the consultation service.</p>
<p><strong>Clinical Specialty Areas</strong></p>
<ul>
<li>pulmonary function</li>
<li>bronchoscopy</li>
<li>pleural disease</li>
<li>general pulmonary medicine</li>
</ul>
<p><strong>Academic and Research Interests </strong></p>
<ul>
<li>lung transplantation</li>
<li>tuberculosis</li>
<li>respiratory failure</li>
<li>World-Trade-Center-related pulmonary disease</li>
<li>history of pulmonary medicine</li>
</ul>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

EMR ID

3427

Is Open Scheduling

Off

Sami A. Nachman

https://assets.montefioreeinstein.org/profiles/images/physphoto/Nachman_Sami_MD_420x504.jpg

First Name

Sami

Last Name

Nachman

NPI

1255491932

Faculty ID

13896

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

5711

Visit Type ID

2542

Is Open Scheduling

On

Zocdoc Link

Ali Y. Mansour

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/707c8b40-470d-11ec-9350-298b34a4a389.jpg

First Name

Ali

Last Name

Mansour

NPI

1427279017

Faculty ID

17102

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

C<span style="color:#525458;font-family:Arial, Helvetica, sans-serif;background-color:#ffffff;">linical focus includes interventional pulmonary medicine, interstitial lung disease, lung transplantation, vascular medicine and sleep medicine.</span><quillbot-extension-portal></quillbot-extension-portal>

Research Focus

<span style="color:#525458;font-family:Arial, Helvetica, sans-serif;background-color:#ffffff;">Dr. Mansour&rsquo;s research focuses on lung transplant and extracorporeal membrane oxygenation (ECMO) support during critical illnesses from severe lung disease.</span><quillbot-extension-portal></quillbot-extension-portal>

Elsevier Profile

EMR ID

124228

Biography

<p style="padding-top:0px;color:#525458;font-family:Arial, Helvetica, sans-serif;background-color:#ffffff;">Ali Mansour, MD, is Medical Director, Advanced Pulmonary Failure and Lung Transplantation and Assistant Professor at Montefiore Einstein. His clinical focus includes interventional pulmonary medicine, interstitial lung disease, lung transplantation, vascular medicine and sleep medicine.</p><p style="padding-top:0px;color:#525458;font-family:Arial, Helvetica, sans-serif;background-color:#ffffff;">In 2000, Dr. Mansour received his Bachelor of Chemistry at the American University of Beirut. He continued his studies at this institution and received his Doctor of Medicine in 2004. Dr. Mansour began his postgraduate training in 2004 with a yearlong internship at the American University of Beirut Medical College. His training then took him to Kansas, where he completed an internship and residency in internal medicine in 2008 at the Kansas University Medical School. Following this, Dr. Mansour completed a fellowship in pulmonary and critical care that included advanced fellowship training in pulmonary transplantation at Baylor College of Medicine in 2011. In 2012, he completed a sleep fellowship at the University Hospital Case Western Medical Center. Dr. Mansour is board certified in echocardiography and vascular medicine and is accredited as an interventional pulmonologist.</p><p style="padding-top:0px;color:#525458;font-family:Arial, Helvetica, sans-serif;background-color:#ffffff;">Dr. Mansour&rsquo;s research focuses on lung transplant and extracorporeal membrane oxygenation (ECMO) support during critical illnesses from severe lung disease. He is also interested in lung cancer staging and advanced airway procedure to improve and prolong survival. More recently, he supervises numerous clinical studies and trials including novel therapies for SARS-CoV-2. His work has been published in a number of peer-reviewed publications, and he has been an invited speaker to numerous national oral presentations.</p><p style="padding-top:0px;color:#525458;font-family:Arial, Helvetica, sans-serif;background-color:#ffffff;">Dr. Mansour is a member of numerous professional societies, including the American Thoracic Society, the American Academy of Sleep Medicine and the American Association for Bronchology and Interventional Pulmonology. He is a fellow of the American College of Chest Physicians.</p>

Is Open Scheduling

Off

Anna Kezerashvili

https://assets.montefioreeinstein.org/profiles/images/physphoto/Kezerashvili_Anna_MD_420x504.jpg

First Name

Anna

Last Name

Kezerashvili

NPI

1245528975

Faculty ID

14543

CMO Specialties

Clinical Terms

Employment Status

part-time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

EMR ID

4598

Is Open Scheduling

Off

Marleine F. Ishak

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/5c9fc3e0-35f4-11ed-8123-8ffce84a9f6a.jpg

First Name

Marleine

Last Name

Ishak

NPI

1639321847

Faculty ID

14583

CMO Specialties

Clinical Terms

Employment Status

part-time

Patient Type

Pediatric

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

EMR ID

73015

Biography

<p>Marleine Ishak, MD, is an attending physician, Respiratory and Sleep Medicine at Children’s Hospital at Montefiore (CHAM) and Assistant Professor, Pediatrics at Montefiore Einstein. Dr Ishak brings unique specialized medical skills, experience and commitment to the care of your child with respiratory disease. She has a particular interest in pediatric asthma and bronchopulmonary dysplasia.</p>

<p>In 2005, Dr. Ishak received her medical degree from the Lebanese University Faculty of Medical Sciences in Beirut, Lebanon. After completing her pediatric residency in 2008 at Saint George Hospital/Balamand in Beirut, she came to the United States and completed her postdoctoral fellowship in pediatric pulmonology at Yale Children’s Hospital in 2011 and her residency in pediatrics at New York-Presbyterian Morgan Stanley Children's Hospital (CHONY) in 2013.</p>

<p>Dr. Ishak’s research focuses on hypoxia. She has shared her work through publication in peer-reviewed journals, book chapters and national presentations.</p>

<p>Dr. Ishak is board certified in both General Pediatrics and Pediatric Pulmonology by the American Board of Pediatrics. She is a member of the American Academy of Pediatrics, American College of Chest Physicians and the American Thoracic Society.</p>

Is Open Scheduling

Off

Michelle Ng Gong

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/328d3b60-bf8b-11ee-b89e-33007638942c.jpg

First Name

Michelle

Last Name

Gong

NPI

1114946233

Faculty ID

11976

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Languages

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Dr. Gong is the Chief of Critical Care Medicine, Chief of Pulmonary Medicine, and Director of Critical Care Research at Montefiore Medical Center and Professor in Medicine and in Epidemiology and Population Health at Albert Einstein College of Medicine. After receiving an engineering degree at the University of Pennsylvania, Dr. Gong went on to earn a medical degree at the Yale University School of Medicine. She then completed her postdoctoral training at the Beth Israel Hospital in medicine and at the Brigham and Women&rsquo;s Hospital in the Harvard Combined Program in Pulmonary and Critical Care Medicine. She also studied at the Harvard School of Public Health, receiving her Master&rsquo;s degree in Clinical Epidemiology. Prior to coming to Albert Einstein College of Medicine and Montefiore Medical Center, she was Assistant Professor of Medicine in the division of Pulmonary, Critical Care and Sleep Medicine at the Mount Sinai School of Medicine.&nbsp; She joined the Einstein/Montefiore faculty in July 2009.</p>
<p>Dr. Gong is recognized nationally and internationally for her expertise in critical care delivery and management of acute respiratory failure and acute respiratory distress syndrome (ARDS).&nbsp; She has spent her career on improving outcomes in patients along the entire continuum of critical illness from its development to its progression and recovery with an overall focus on the prediction and prevention of acute organ failure and their complications.&nbsp; Nationally, she is a well-respected clinical researcher and trialist in acute injury and critical illness.&nbsp; &nbsp;Continuously funded by the NIH for over 20 years for her work, her research ranges from COVID-19 and ARDS to prevention of delirium, treatment of severe influenza, big data and predictive analytics in risk prediction, and effective clinical decision support systems. Her research has been published in the New England Journal of Medicine and JAMA.&nbsp; She has also been funded by the AHRQ on clinical decision making in ARDS&nbsp; and by the NHLBI for the Montefiore-Sinai Clinical Center for the PETAL Clinical Trials Network focused on the prevention and early treatment of ARDS.</p>
<p>A model clinician-researcher, her scientific projects influence her clinical care, and her patients motivates her research. So it is not surprising that some of her proudest achievements have occurred within her clinical work to improve outcomes for patients within Montefiore.&nbsp; This has included process improvement projects such as the implementation of sedation and delirium protocols and early mobilization in the medical intensive care unit that has reduced duration of mechanical ventilation, length of stay, hospital costs and ICU complications.&nbsp; She has also worked on the incorporation of artificial intelligence to help identify patients at increased risk of poor outcomes at Montefiore and evaluation of clinical decision support systems. She has co-authored the Surviving Sepsis Guidelines on management of patients with COVID-19, published in Intensive Care Medicine.&nbsp;</p>
<p>Dr. Gong is a well-regarded leader in the field of pulmonary and critical care medicine.&nbsp; She is a graduate of the prestigious Executive Leadership in Academic Medicine Fellowship and was the former or current chair of the Critical Care Planning Committee and the Critical Care Assembly for the American Thoracic Society. She is also on the Discovery Oversight Committee that helps plan the direction and agenda for the clinical trials initiative of the Society of Critical Care Medicine.&nbsp; Dr. Gong was awarded the Gotham Icon Award for Champions and Change Makers of New York City by the Museum of the City of New York in 2020. Given her expertise, she has been named to multiple panels to develop clinical practice guidelines, including the American College of Chest Physicians and the American Thoracic Society clinical practice guidelines for liberation from mechanical ventilation and the Surviving Sepsis Campaign guidelines for management of severe COVID-19 in 2020.&nbsp; In these leadership positions, she has had the fortune and privilege to mentor residents, fellows and junior investigators both within and beyond Montefiore into productive, academic careers in medicine.</p>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Dr. Gong&rsquo;s clinical focus is on critical care delivery, predictive analytics, and process improvements, such as the implementation of sedation and delirium protocols and early mobilization in the medical intensive care unit, which has reduced the duration of mechanical ventilation, length of stay, hospital costs, and ICU complications.

Research Focus

Current research ranges from acute respiratory distress syndrome to prevention of delirium, treatment of severe influenza, big data and predictive analysis in risk prediction, and effective clinical decision support systems.

Elsevier Profile

EMR ID

5230

Biography

<p>Michelle N. Gong, MD, MS, is a Professor of Medicine and Epidemiology and Population Health at Albert Einstein College of Medicine. She is also the Chief of Critical Care Medicine, Associate Chief of Academic Affairs, and Director of Critical Care Research at Montefiore. Dr. Gong&rsquo;s clinical focus is on critical care delivery, predictive analytics, and process improvements, such as the implementation of sedation and delirium protocols and early mobilization in the medical intensive care unit, which has reduced the duration of mechanical ventilation, length of stay, hospital costs, and ICU complications. She joined the Einstein/Montefiore faculty in July 2009.</p> <p>Dr. Gong received an Engineering degree at the University of Pennsylvania. She then went on to earn her Doctor of Medicine at the Yale University School of Medicine. She completed her postdoctoral training at the Beth Israel Hospital in medicine and at the Brigham and Women&rsquo;s Hospital in the Harvard Combined Program in Pulmonary and Critical Care Medicine. Dr. Gong studied at the Harvard School of Public Health, receiving her Master&rsquo;s Degree in Clinical Epidemiology. </p>Dr. Gong has spent her career improving outcomes in patients along the entire continuum of critical illness, from its development to progression and recovery, with an overall focus on the prediction and prevention of acute organ failure and its complications. Her current research ranges from acute respiratory distress syndrome to prevention of delirium, treatment of severe influenza, big data and predictive analysis in risk prediction, and effective clinical decision support systems. Under her leadership, Montefiore/Einstein was selected as a clinical center for the NHLBI Prevention and Early Treatment of Acute Lung Injury (PETAL) Clinical Trials Network which represents the first representation of a medical center from the New York and the tri-state area. Collaborating with the research informatics and healthcare industries, Dr. Gong has fostered the application of informatic approaches to drive improvement in healthcare delivery and research.</p><p>In 2013, Dr. Gong received the ATS Innovation in Fellowship Education Award. She is board certified by the American Board of Internal Medicine in Internal Medicine, Critical Care Medicine, Palliative Care Medicine, and Pulmonary Medicine. </p>

Is Open Scheduling

Off

Mona Gangar

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/a6a37e20-24e4-11ee-88ab-4d123afddc94.jpg

First Name

Mona

Last Name

Gangar

NPI

1679700629

Faculty ID

13581

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Clinical Focus

Clinical interests are in all aspects of pediatric otorhinolaryngology with a focus on pediatric head and neck pathology, and special interests in pediatric thyroid disease, vascular anomalies, resident/medical student education and global health.<quillbot-extension-portal></quillbot-extension-portal>

Research Focus

Dr. Gangar&rsquo;s research focuses on all aspects of pediatric otorhinolaryngology.&nbsp;<quillbot-extension-portal></quillbot-extension-portal>

Elsevier Profile

EMR ID

4801

Biography

<p>Mona Gangar, MD, MS, is Director. Medical Students; Co-director, Pediatric thyroid program; Faculty Advisor, ENT interest group and Assistant Professor of Otorhinolaryngology&ndash;Head &amp; Neck Surgery at Montefiore-Einstein. Her clinical interests are in all aspects of pediatric otorhinolaryngology with a focus on pediatric head and neck pathology, and special interests in pediatric thyroid disease, vascular anomalies, resident/medical student education and global health.</p><p>In 1999, Dr. Gangar received her Bachelor of Science in neuroscience from the University of California Los Angeles. She attended MCP Hahnemann University from 2000 to 2002, earning her Master of Science in medical science. She then attended New York Medical College to pursue her Doctor of Medicine degree, earning it in 2006. Her postdoctoral training included an otorhinolaryngology&ndash;head and neck surgery residency at Einstein from 2006 to 2011, followed by a yearlong fellowship in pediatric otolaryngology at Rady&rsquo;s Children&rsquo;s Hospital, which she completed in 2012.</p><p>Dr. Gangar&rsquo;s research focuses on all aspects of pediatric otorhinolaryngology. She has shared her work through publication in journals and podium and poster presentations.</p><p>Dr. Gangar is board certified and is a member of the American Academy of Otolaryngology&ndash;Head and Neck Surgery and the American Society of Pediatric Otolaryngology.</p>

Is Open Scheduling

Off

Daniel G. Fein

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/f3b8e360-8834-11ec-8359-516abccc70f6.jpg

First Name

Daniel

Last Name

Fein

NPI

1336399757

Faculty ID

14705

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p><strong>Education</strong></p>
<p>Dr. Daniel Fein completed a medical degree at NYU School of Medicine and an internal medicine residency at Boston University Medical Center. Following residency, he spent five months serving as medical director of the Hillside Health Care Center in Toledo, Belize, and completed fellowship training in pulmonary and critical care at Mount Sinai Beth Israel.</p>
<p><strong>Administrative</strong></p>
<p>Dr. Fein is the director of inpatient pulmonary services for Montefiore Medical Center and the director of the medical and surgical intensive care unit at Montefiore Wakefield where he also serves as the site director for both pulmonary and critical care. Between 2019 and 2022 Dr. Fein served as &nbsp;the web director for the critical care assembly of the American Thoracic Society.&nbsp;&nbsp;</p>
<p><strong>Clinical Specialties</strong></p>
<ul>
<li>Emergency airway management&nbsp;</li>
<li>Ventilator management</li>
<li>Thoracic point of care critical care ultrasound&nbsp;</li>
<li>Chronic obstructive pulmonary disease</li>
</ul>

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

Selected Publications

<p class="Body" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman'; border: none;"><strong><span style="font-size: 11pt; color: windowtext;">A. Original Communications in Reviewed Journals</span></strong></p>
<p class="Body" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman'; border: none;"><span style="font-size: 11pt; color: windowtext;">Apter A, Cheng J, Small D, Bennett I, Albert C,&nbsp;<strong>Fein D</strong>, George M, Van Horne S. Asthma Numeracy Skill and Health Literacy. Journal of Asthma 2006;43:705-710.&nbsp;</span></p>
<p class="Body" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman'; border: none;"><span style="font-size: 11pt; color: windowtext;">&nbsp;</span></p>
<p class="Body" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman'; border: none;"><span style="font-size: 11pt; color: windowtext;">Walkey A,&nbsp;<strong>Fein D</strong>, Horbowicz K, Farber H. Differential Response to Intravenous Prostacyclin Analog Therapy in Patients with Pulmonary Arterial Hypertension. Pulmonary Pharmacology and Therapeutics 2011;24:421-5.</span></p>
<p class="Body" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman'; border: none;"><span style="font-size: 11pt;">&nbsp;</span></p>
<p class="Body" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman'; border: none;"><span style="font-size: 11pt;">Sampat D, Filopei J, Rao P,&nbsp;<strong>Fein D</strong>, Acquah S. Full circle: Extranodal marginal zone B-cell lymphoma of the trachea. Lung Cancer. 2017 Sep;111:12-14.</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><span style="font-size: 11pt; font-family: Arial;">&nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><span style="font-size: 11pt;">Hsieh SJ, Otusanya O, Gershengorn HB, Hope AA, Dayton C, Levi D, Garcia M, Prince D, Mills M,&nbsp;<strong>Fein D</strong>, Colman S, Gong MN. Staged Implementation of Awakening and Breathing, Coordination, Delirium Monitoring and Management, and Early Mobilization Bundle Improves Patient Outcomes and Reduces Hospital Costs. Crit Care Med. 2019 Apr;10</span><span style="font-size: 11pt; border: none;"><span style="border: none;">47:885-893.</span></span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><span style="font-size: 11pt;">&nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><span style="font-size: 11pt;">Archontakis P, Palaiodimos L, Fleitas Sosa D, Benes L, Gulani P,&nbsp;<strong>Fein D</strong>. Combination of low-dose glucocorticosteroids and mineralocorticoids as adjunct therapy for adult patients with septic shock: A systematic review and meta-analysis of randomized trials and observational studies.&nbsp;</span><span lang="NO-BOK" style="font-size: 11pt;">Avicenna J Med 2019;9:134-42.</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><span style="font-size: 11pt;">&nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><strong><span style="font-size: 11pt;">Fein DG</span></strong><span style="font-size: 11pt;">, Eisen LA. Video Body Cameras Bridge the Gap Between Simulation and Patient Care During Emergency Airway Management. Chest 2020;158:24-5.</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><span style="font-size: 11pt;">&nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><span style="font-size: 11pt;">Chua A, Murphy C, Hameed S, Weston G, Abramowitz M, Gershengorn H,&nbsp;<strong>Fein DG</strong>. Inferior vena cava filters do not increase the risk&nbsp;of&nbsp;bloodstream&nbsp;infections in patients with newly diagnosed VTE. Am J Infect Control. 2020: 10.1016/j.ajic.2020.05.029. [Epub ahead of print]</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><span style="font-size: 11pt;">&nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><span style="font-size: 11pt;">Kim Y, Dym AA, Yang K,&nbsp;<strong>Fein DG</strong>, et al. The Effect of Numbered Jerseys on Directed Commands, Teamwork, and Clinical Performance During Simulated Emergencies. J Healthc Qual 2021;43:24-31.</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><span style="font-size: 11pt;">&nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><strong><span style="font-size: 11pt;">Fein DG</span></strong><span style="font-size: 11pt;">, Mastroianni F, Murphy CG, et al. Impact of a Critical Care Specialist Intervention on First Pass Success for Emergency Airway Management Outside the ICU. Journal of Intensive Care Medicine 2021;36:80-8.</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><span style="font-size: 11pt;">&nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><strong><span style="font-size: 11pt;">Fein DG</span></strong><span style="font-size: 11pt;">, Zhao D, Swartz K, et al. The Impact of Nighttime on First Pass Success During the Emergent Endotracheal Intubation of Critically Ill Patients. Journal of Intensive Care Medicine 2021;36:1498-506.</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><span style="font-family: Helvetica; border: none;">&nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><span style="font-size: 11pt;">Goligher EC, Bradbury CA, McVerry BJ, et al. (collaborator) Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19. The New England Journal of Medicine 2021;385:777-89.</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><span style="font-size: 11pt;">&nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><span style="font-size: 11pt;">Lawler PR, Goligher EC, Berger JS, et al. (collaborator) Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19. The New England Journal of Medicine 2021;385:790-802.</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><span style="font-size: 11pt;">&nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><span style="font-size: 11pt;">Keene AB, Shiloh AL, Eisen L, Berger J, Karwa M,&nbsp;<strong>Fein D</strong>, Orsi D, Gong M.&nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><span style="font-size: 11pt;">et al. Critical Care Surge During the COVID-19 Pandemic: Implementation and Feedback From Frontline Providers. Journal of Intensive Care Medicine 2021;36:233-40.</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><span style="font-size: 11pt;">&nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><span style="font-size: 11pt;">Russotto V, Myatra SN, Laffey JG, et al. (site principle investigator) Intubation Practices and Adverse Peri-intubation Events in Critically Ill Patients From 29 Countries. JAMA 2021;325:1164-72.</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><span style="font-size: 11pt;">&nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><span style="font-size: 11pt;">Nauka PC, Chen JT, Shiloh AL, Eisen LA,&nbsp;<strong>Fein DG</strong>. Practice, Outcomes, and Complications of Emergent Endotracheal Intubation by Critical Care Practitioners During the COVID-19 Pandemic. Chest 2021;160:2112-22.</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><span style="font-size: 11pt;">&nbsp;</span></p>
<p class="Body" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman'; border: none;"><strong><span style="font-size: 11pt;">B. Books, Chapters in Books and Review Articles&nbsp;</span></strong></p>
<p class="Body" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman'; border: none;"><strong><span style="font-size: 11pt;">&nbsp;</span></strong></p>
<p class="Body" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman'; border: none;"><strong><span style="font-size: 11pt;">Fein D</span></strong><span style="font-size: 11pt;">, Tofts R, Kory P. Thoracic Ultrasound Image Acquisition. Point-of-Care Ultrasound. Soni N, Arntfield R, Kory P. Saunders; 2014.&nbsp;</span></p>
<p class="Body" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman'; border: none;"><span style="font-size: 11pt;">&nbsp;</span></p>
<p class="Body" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman'; border: none;"><strong><span style="font-size: 11pt;">Fein D</span></strong><span style="font-size: 11pt;">, Verzosa S, Walker P. Cystic Lung Disease. Pulmonary Disease Examination and Board Review. Go R. McGraw Hill; 2016.&nbsp;</span></p>
<p class="Body" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman'; border: none;"><span style="font-size: 11pt;">&nbsp;</span></p>
<p class="Body" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman'; border: none;"><strong><span style="font-size: 11pt;">Fein D</span></strong><span style="font-size: 11pt;">, Verzosa S, Walker P. Bronchiectasis. Pulmonary Disease Examination and Board Review. Go R. McGraw Hill; 2016.</span></p>
<p class="Body" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman'; border: none;"><span style="font-size: 11pt;">&nbsp;</span></p>
<p class="Body" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman'; border: none;"><strong><span style="font-size: 11pt; color: windowtext;">Fein DG</span></strong><span style="font-size: 11pt; color: windowtext;">, Zaidi AN, Sulica R. Pulmonary Hypertension Due to Common Respiratory Conditions: Classification, Evaluation and Management Strategies</span><span style="font-size: 11pt;">. Journal of Clinical Medicine 2016;26;5:9.&nbsp;</span></p>
<p class="Body" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman'; border: none;"><span style="font-size: 11pt;">&nbsp;</span></p>
<p class="Body" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman'; border: none;"><strong><span style="font-size: 11pt;">Fein D</span></strong><span style="font-size: 11pt;">, Abbasi M. Thoracic Ultrasound Image Acquisition. Point-of-Care Ultrasound, second edition. Soni N, Arntfield R, Kory P. Saunders; 2019.</span></p>
<p class="Body" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman'; border: none;"><span style="font-size: 11pt;">&nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman'; border: none;"><span style="font-size: 11pt;">Douglas IS, Bednash JS,&nbsp;<strong>Fein DG</strong>, Mallampalli RK, Mansoori J, Gershengorn HB. Update in Critical Care / ARDS 2018. Am J Respir Crit Care Med. 2019 Jun; 199:1335-1343.&nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman'; border: none;"><span style="font-size: 11pt;">&nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman'; border: none;"><span style="font-size: 11pt;">Islam M, Levitus M, Eisen L, Shiloh AL,&nbsp;<strong>Fein D</strong>. Lung Ultrasound for the Diagnosis and Management of Acute Respiratory Failure. Lung 2020. [Epub ahead of print]</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman'; border: none;"><span style="font-size: 11pt;">&nbsp;</span></p>

EMR ID

77832

Biography

<p>Daniel G. Fein, MD, is Director, Inpatient Pulmonary Services, Director, Pulmonary and Critical Care Medicine, Director, Medical Surgical Intensive Care Unit and Associate Professor, Medicine at Montefiore Einstein. Dr. Fein&rsquo;s clinical focus centers on emergency airway management, acute respiratory failure, shock and chronic obstructive pulmonary disease.</p><p>After obtaining his Bachelor of Science from Lehigh University in 2002, Dr. Fein earned his Doctor of Medicine at New York University in 2008. He then completed his internal medicine residency at Boston University in 2011, followed by a fellowship in pulmonary and critical care medicine at Mount Sinai Beth Israel in 2015.</p><p>Dr. Fein&rsquo;s research focus pertains to the practice and management of emergency airway management and acute respiratory failure. He has shared his work through numerous invited presentations, peer-reviewed journals, books, chapters, review articles and abstracts. He has also been a reviewer for scientific journals including the <em>Journal of Clinical Medicine</em>, the <em>Journal of Intensive Care Medicine, CHEST Journal</em> and <em>BMJ Open Access</em>.</p><p>Dr. Fein is board certified by the American Board of Internal Medicine in Pulmonary Disease and Critical Care Medicine. He is a member of the American College of Chest Physicians (ACCP) and the American Thoracic Society (ATS). In 2021, Dr. Fein was recognized as a Leo M. Davidoff Society Honoree. In 2023, he received the Quality Improvement Champion Award from the United Hospital Fund Tribute to Excellence.</p>

Is Open Scheduling

On